These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27986495)

  • 21. Targeted therapy for cystic fibrosis: cystic fibrosis transmembrane conductance regulator mutation-specific pharmacologic strategies.
    Rubenstein RC
    Mol Diagn Ther; 2006; 10(5):293-301. PubMed ID: 17022692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.
    Solomon GM; Marshall SG; Ramsey BW; Rowe SM
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40(0 40):S3-S13. PubMed ID: 26097168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging drugs for cystic fibrosis.
    Amin R; Ratjen F
    Expert Opin Emerg Drugs; 2014 Mar; 19(1):143-55. PubMed ID: 24479826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of Cystic Fibrosis with CFTR Modulators].
    Tümmler B
    Pneumologie; 2016 May; 70(5):301-13. PubMed ID: 26894479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized medicine in cystic fibrosis: dawning of a new era.
    Clancy JP; Jain M
    Am J Respir Crit Care Med; 2012 Oct; 186(7):593-7. PubMed ID: 22723294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal cystic fibrosis care.
    Antunovic SS; Lukac M; Vujovic D
    Clin Pharmacol Ther; 2013 Jan; 93(1):86-97. PubMed ID: 23149927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The increasing challenge of genetic counseling for cystic fibrosis.
    Foil KE; Powers A; Raraigh KS; Wallis K; Southern KW; Salinas D
    J Cyst Fibros; 2019 Mar; 18(2):167-174. PubMed ID: 30527892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis: toward personalized therapies.
    Ikpa PT; Bijvelds MJ; de Jonge HR
    Int J Biochem Cell Biol; 2014 Jul; 52():192-200. PubMed ID: 24561283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
    Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
    Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect.
    Boyle MP; De Boeck K
    Lancet Respir Med; 2013 Apr; 1(2):158-63. PubMed ID: 24429096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lumacaftor/ivacaftor, a novel agent for the treatment of cystic fibrosis patients who are homozygous for the F580del CFTR mutation.
    Bulloch MN; Hanna C; Giovane R
    Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1055-1072. PubMed ID: 28891346
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precision Genomic Medicine in Cystic Fibrosis.
    Chang EH; Zabner J
    Clin Transl Sci; 2015 Oct; 8(5):606-10. PubMed ID: 26073768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translating the genetics of cystic fibrosis to personalized medicine.
    Corvol H; Thompson KE; Tabary O; le Rouzic P; Guillot L
    Transl Res; 2016 Feb; 168():40-49. PubMed ID: 25940043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing the Paradigm - Treating the Basic Defect in Cystic Fibrosis.
    Guglani L
    Indian J Pediatr; 2015 Aug; 82(8):727-36. PubMed ID: 26077199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning.
    Barry PJ; Ronan N; Plant BJ
    Semin Respir Crit Care Med; 2015 Apr; 36(2):287-98. PubMed ID: 25826594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [FUTURE THERAPIES FOR CYSTIC FIBROSIS].
    Fajac I
    Rev Prat; 2015 Oct; 65(8):1106-8. PubMed ID: 26749719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalised medicine for cystic fibrosis: treating the basic defect.
    Elborn JS
    Eur Respir Rev; 2013 Mar; 22(127):3-5. PubMed ID: 23457158
    [No Abstract]   [Full Text] [Related]  

  • 39. Cystic Fibrosis and Its Management Through Established and Emerging Therapies.
    Spielberg DR; Clancy JP
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():155-75. PubMed ID: 26905785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cystic fibrosis: therapies targeting specific gene defects.
    Thursfield RM; Davies JC
    Paediatr Respir Rev; 2012 Dec; 13(4):215-9. PubMed ID: 23069118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.